{"id":887452,"date":"2026-06-23T15:35:16","date_gmt":"2026-06-23T15:35:16","guid":{"rendered":"https:\/\/www.europesays.com\/us\/887452\/"},"modified":"2026-06-23T15:35:16","modified_gmt":"2026-06-23T15:35:16","slug":"rising-pharma-holdings-recalls-11460-bottles-of-blood-pressure-tablets","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/887452\/","title":{"rendered":"Rising Pharma Holdings recalls 11,460 bottles of blood pressure tablets"},"content":{"rendered":"<p class=\"default__StyledText-sc-tl066j-0 jyMHRV body-paragraph\">Thousands of bottles of blood pressure medications have been recalled, the <a href=\"https:\/\/www.accessdata.fda.gov\/scripts\/ires\/?Event=99136\" target=\"_blank\" rel=\"noreferrer nofollow noopener\" title=\"https:\/\/www.accessdata.fda.gov\/scripts\/ires\/?Event=99136\">Food and Drug Administration<\/a> announced. <\/p>\n<p class=\"default__StyledText-sc-tl066j-0 jyMHRV body-paragraph\">The recall affects 25mg chlorthalidone tablets that came in bottles of 100 or 1000 tablets and is due to the medication failing dissolution specifications, the <a href=\"https:\/\/www.accessdata.fda.gov\/scripts\/ires\/?Event=99136\" target=\"_blank\" rel=\"noreferrer nofollow noopener\" title=\"https:\/\/www.accessdata.fda.gov\/scripts\/ires\/?Event=99136\">agency<\/a> said. <\/p>\n<p class=\"default__StyledText-sc-tl066j-0 jyMHRV body-paragraph\">The 100-tablet bottle has NDC 64980-599-01, while the 1000-tablet bottle has NDC 64980-599-10.<\/p>\n<p class=\"default__StyledText-sc-tl066j-0 jyMHRV body-paragraph\">The 11,460 recalled bottles were distributed nationwide by Rising Pharma Holdings.<\/p>\n<p class=\"default__StyledText-sc-tl066j-0 jyMHRV body-paragraph\">The recall was initially issued on June 5 but was classified as a Class II recall on June 22. <\/p>\n<p class=\"default__StyledText-sc-tl066j-0 jyMHRV body-paragraph\">A Class II recall is when there is \u201ca situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote,\u201d the <a href=\"https:\/\/www.fda.gov\/safety\/industry-guidance-recalls\/recalls-background-and-definitions\" target=\"_blank\" rel=\"noreferrer nofollow noopener\" title=\"https:\/\/www.fda.gov\/safety\/industry-guidance-recalls\/recalls-background-and-definitions\">FDA<\/a> explains.<\/p>\n<p class=\"default__StyledText-sc-tl066j-0 jyMHRV body-paragraph\">Chlorthalidone is used by itself or with other pills to treat high blood pressure, as well as fluid retention (edema) caused by severe liver disease, kidney disease or steroid and hormone treatments, the <a href=\"https:\/\/www.mayoclinic.org\/drugs-supplements\/chlorthalidone-oral-route\/description\/drg-20071817\" target=\"_blank\" rel=\"noreferrer nofollow noopener\" title=\"https:\/\/www.mayoclinic.org\/drugs-supplements\/chlorthalidone-oral-route\/description\/drg-20071817\">Mayo Clinic<\/a> said. <\/p>\n<p class=\"default__StyledText-sc-tl066j-0 jyMHRV body-paragraph body-copyright\">\u00a92026 Cox Media Group<\/p>\n","protected":false},"excerpt":{"rendered":"Thousands of bottles of blood pressure medications have been recalled, the Food and Drug Administration announced. The recall&hellip;\n","protected":false},"author":3,"featured_media":887453,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[34],"tags":[278104,359210,151,210,169258,1060,22749,169259,12310,360015,67,132,68],"class_list":["post-887452","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-blood-pressure-medications","tag-chlorthalidone","tag-fda","tag-health","tag-latest-recall","tag-medication","tag-recall","tag-recall-alert","tag-recalls","tag-rising-pharma-holdings","tag-united-states","tag-unitedstates","tag-us"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/116800161508268658","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/887452","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=887452"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/887452\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/887453"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=887452"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=887452"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=887452"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}